课题基金 / 基金详情

项目摘要

项目成果

Eric Vallabh Minikel的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 VPSPr是一种罕见的神经退行性疾病,临床表现为 路易体痴呆或额颞叶变性,但在神经病理学上与沉积物有关 感染性但对蛋白酶敏感的朊病毒蛋白(PrP)聚集体。VPSPr病例缺乏朊病毒突变 蛋白质基因(PRNP),但42%的病例有阳性家族史,符合遗传性疾病, 中度昏迷我们将应用全外显子组测序和深度靶向测序来查询 VPSPr的遗传基础VPSPr的遗传原因的鉴定将有助于朊病毒的鉴别诊断 疾病和阿尔茨海默氏症相关的痴呆症,验证新的基因组技术, 神经退行性疾病,并确定导致神经退行性疾病的新的细胞通路。
英文摘要
PROJECT SUMMARY First characterized one decade ago, VPSPr is a rare neurodegenerative disease that presents clinically as Lewy body dementia or frontotemporal lobar degeneration but has been neuropathologically linked to deposits of infectious but protease-sensitive prion protein (PrP) aggregates. VPSPr cases lack mutations in the prion protein gene (PRNP) but 42% of cases have a positive family history, consistent with a genetic disease of moderate penetrance. We will apply whole exome sequencing and deep targeted sequencing to query the genetic basis of VPSPr. Identification of a genetic cause of VPSPr will aid in the differential diagnosis of prion disease and Alzheimer’s-related dementias, validate new genomic technologies for understanding neurodegeneration, and identify new cellular pathways that lead to neurodegenerative disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancement of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease
  • 批准号:
    10721465
  • 项目类别:
  • 资助金额:
    $80.05万
  • 财政年份:
    2023
  • 负责人:
    Eric Vallabh Minikel
  • 依托单位:
Research Project 3
  • 批准号:
    10669496
  • 项目类别:
  • 资助金额:
    $102.9万
  • 财政年份:
    2023
  • 负责人:
    Eric Vallabh Minikel
  • 依托单位:
Research Project 2
  • 批准号:
    10669495
  • 项目类别:
  • 资助金额:
    $75.63万
  • 财政年份:
    2023
  • 负责人:
    Eric Vallabh Minikel
  • 依托单位:
Development of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease
  • 批准号:
    10549815
  • 项目类别:
  • 资助金额:
    $38.77万
  • 财政年份:
    2021
  • 负责人:
    Eric Vallabh Minikel
  • 依托单位:
海外基金